key: cord-0302027-c80hle1p authors: Martínez-Colón, Giovanny J.; Ratnasiri, Kalani; Chen, Heping; Jiang, Sizun; Zanley, Elizabeth; Rustagi, Arjun; Verma, Renu; Chen, Han; Andrews, Jason R.; Mertz, Kirsten D.; Tzankov, Alexandar; Azagury, Dan; Boyd, Jack; Nolan, Garry P.; Schürch, Christian M.; Matter, Matthias S.; Blish, Catherine A.; McLaughlin, Tracey L. title: SARS-CoV-2 infects human adipose tissue and elicits an inflammatory response consistent with severe COVID-19 date: 2021-10-24 journal: bioRxiv DOI: 10.1101/2021.10.24.465626 sha: 17f8101ac3e207787e1d32114169ccd389ee058c doc_id: 302027 cord_uid: c80hle1p The COVID-19 pandemic, caused by the viral pathogen SARS-CoV-2, has taken the lives of millions of individuals around the world. Obesity is associated with adverse COVID-19 outcomes, but the underlying mechanism is unknown. In this report, we demonstrate that human adipose tissue from multiple depots is permissive to SARS-CoV-2 infection and that infection elicits an inflammatory response, including the secretion of known inflammatory mediators of severe COVID-19. We identify two cellular targets of SARS-CoV-2 infection in adipose tissue: mature adipocytes and adipose tissue macrophages. Adipose tissue macrophage infection is largely restricted to a highly inflammatory subpopulation of macrophages, present at baseline, that is further activated in response to SARS-CoV-2 infection. Preadipocytes, while not infected, adopt a proinflammatory phenotype. We further demonstrate that SARS-CoV-2 RNA is detectable in adipocytes in COVID-19 autopsy cases and is associated with an inflammatory infiltrate. Collectively, our findings indicate that adipose tissue supports SARS-CoV-2 infection and pathogenic inflammation and may explain the link between obesity and severe COVID-19. One sentence summary Our work provides the first in vivo evidence of SARS-CoV-2 infection in human adipose tissue and describes the associated inflammation. The COVID-19 pandemic, caused by the viral pathogen SARS-CoV-2, has infected over 250 190 To comprehensively characterize the cells infected with SARS-CoV-2 in human adipose tissue, 191 we performed single-cell RNA sequencing (scRNA-seq) of SARS-CoV-2 and mock-infected 192 SVC isolated from both SAT and VAT from three bariatric surgery patients ( Fig. 2A, table S3 ). 193 We generated 198,759 single-cell expression profiles. After performing dimensionality reduction 194 and Harmony batch integration (29), unbiased graph-based clustering resulted in 23 cell types 195 (C0-C22) with marker genes that aligned with previous datasets and included three major cell 196 groups: preadipocytes, immune cells, and endothelial cells (30, 31) (Fig. 2B, table S3, fig. S5 ). 197 We saw the greatest heterogeneity across the preadipocyte population for which we identified 14 198 distinct clusters, each of which was labeled by its top two cluster defining genes. We similarly 199 labeled two distinct macrophage clusters. Cov-2-exposed samples colored by viral counts-per-million (cpm) showed that macrophages 205 contained the highest concentration of SARS-CoV-2 transcripts (Fig. 2D) , with >85% of SARS- 206 CoV-2 exposed C2-macrophages and >11% C12-macrophages containing more than ten viral 207 transcripts (Fig. 2E ). ACE2 transcript was not detected in the SVC macrophages and therefore 208 14 could not explain the difference in infection levels between C2-macrophages and C12-209 macrophages (Fig. 2F, 2G) . However, C2-macrophages expressed higher levels of BSG, NRP1/2, 210 CTSB and CTSL compared to C12-macrophages (Fig. 2G) , all previously noted to be important 211 to SARS-CoV-2 infection and viral processing (32-34). Our data suggest that these alternative 212 entry receptors could contribute to SARS-CoV-2 entry into C2-macrophages. To further evaluate how these two macrophage populations differ in SARS-CoV-2 susceptibility, 215 we examined the most differentially expressed genes between the macrophage cluster that was CoV-2 + cells versus bystanders highlights the enrichment of pathways associated with IL-10 253 16 signaling (Fig. 3D, table S8 ), which is consistent with upregulation of this pathway in monocytes 254 of severe COVID-19 patients (40). Chemokine and other innate immune system-associated 255 pathways are also highly enriched in infected cells (Fig. 3D ), which has been previously 256 demonstrated (41). Interestingly, there is a reduced enrichment in pathways related to translation 257 machinery of the host, which is supported by SARS-CoV-2 studies suggesting that SARS-CoV-2 258 infection has the ability to reshape translation, splicing, protein homeostasis and nucleic acid 259 metabolism pathways (42, 43). Thus, the macrophages with detectable SARS-CoV-2 RNA 260 display a dramatic transcriptional response with upregulation of inflammatory pathways. Infection induced both ISGs and cytokines, but SAT demonstrated a greater increase in ISG and 302 cytokine responses than did VAT. These data also revealed that in these three participants, the 303 VAT depot has a higher baseline cytokine expression that is further increased upon SARS-CoV-304 2 exposure (Fig. 4D, fig. S9A ). Next, we wanted to see whether particular preadipocyte clusters within the SAT and VAT 307 showed a stronger response to SARS-CoV-2 exposure. We employed perturbation analysis perturbed clusters, this analysis demonstrated that SAT showed consistently stronger 313 perturbation than VAT upon SARS-CoV-2 infection. Therefore, we then focused on the SAT to 314 understand the particular pathways by cluster that contribute to the overall inflammatory 315 20 response in the depot. To do this, we identified the DEGs between SARS-CoV-2 exposed versus 316 mock preadipocytes by cluster, depot, and participant and employed gene set enrichment analysis 317 using the Reactome database to identify relevant pathways to understand the response within 318 each participant and each cluster (Fig. 4F , table S10-13). Clusters P5 and P2 consistently showed 319 transcriptional enrichment for genes relevant to an immune response, more specifically related to 320 cytokine signaling. Additionally, pathway analysis by cluster and participant shows that in 321 participant 1 and 2, which seemed to have a more dramatic response to SARS-CoV-2 infection, Table 1 . 80-plex Luminex analysis of stromal vascular cells from human adipose tissue 340 exposed to SARS-CoV-2. (Table 1 ). In both SAT and VAT, the elevated 367 production of IP-10 is particularly noteworthy as this cytokine has been reported to be elevated undifferentiated preadipocytes (day 0) but was detected by day 3 in SAT, VAT, and PAT (table 412 S2B ). Adipocytes differentiated from PAT were infected at days 3, 6, and 13 of differentiation. 413 We detected SARS-CoV-2 (N gene) at 24 hpi in all differentiated adipocytes (Fig. 5B) . SARS-CoV-2 is detected in the adipose tissue from deceased COVID-19 patients. 436 We next sought to find evidence for SARS-CoV-2 infection of adipose tissue in vivo. We 437 performed RTqPCR for SARS-CoV-2 genes in lung, fat, heart, and kidney tissue samples in a 438 cohort of eight COVID-19 autopsy cases ( In addition to detecting SARS-CoV-2 in the lung and heart, we also detected SARS-CoV-2 in 441 epicardial, visceral, and subcutaneous adipose tissue and kidney ( Table 2) . As expected, SARS- CoV-2 detection was highest in the lung (mean Ct=25). Interestingly, it was followed by adipose 443 tissue (mean Ct=33), heart (mean Ct=34) and kidney (mean Ct=34). In addition, we performed Here, we report that SARS-CoV-2 infects human adipose tissue in COVID-19 patients and in 465 vitro. Significantly extending a prior report that human adipocytes can be infected in vitro (15), 466 we identify both tissue-resident macrophages and mature adipocytes as target cells for SARS- CoV-2 infection (16, 17, 19) . Additionally, this study reveals that in vitro infection leads to We also found that SARS-CoV-2 can infect human adipocytes both in vitro and in vivo. 533 Previously, researchers demonstrated that SARS-CoV-2 is detectable in adipose tissue of SARS- To remove samples from BSL3 containment, supernatants were thawed and mixed with 10% Table S10 . Differentially expressed genes between SARS-CoV-2 exposed versus mock exposed 830 preadipocytes, by cluster and participant, within the SAT 831 Table S11 . Differentially expressed genes between SARS-CoV-2 exposed versus mock exposed 832 preadipocytes, by cluster and participant, within the VAT. Table S12. Reactome pathways for differentially expressed genes between SARS-CoV-2 834 exposed versus mock exposed preadipocytes, by cluster and participant, within the SAT. Table S13. Reactome pathways for differentially expressed genes between SARS-CoV-2 836 exposed versus mock exposed preadipocytes, by cluster and participant, within the VAT. Table S14. ISG and cytokine gene modules. Extrapulmonary manifestations of COVID-19 Factors associated with hospital admission and critical 848 illness among 5279 people with coronavirus disease High Prevalence of Obesity in Severe Acute 855 Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical 856 Ventilation Clinical predictors of mortality due to 858 COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intens Care Med 859 Obesity and Mortality Among Patients Diagnosed With COVID-19: Results 863 From an Integrated Health Care Organization Individuals with obesity and COVID-19: A global 866 perspective on the epidemiology and biological relationships Obesity prolongs the hospital stay in patients affected by COVID-19, and may 869 impact on SARS-COV-2 shedding Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study Obesity and respiratory diseases Prevalence of insulin 878 resistance and associated cardiovascular disease risk factors among normal weight, overweight, 879 and obese individuals Comparison 881 of Plasminogen Activator Inhibitor-1 Concentration in Insulin-Resistant Versus Insulin-Sensitive Role of innate and adaptive 884 immunity in obesity-associated metabolic disease Obesity Increases the Duration of Influenza A Virus Shedding in Adults Hyperglycemia in Acute COVID-19 is Characterized by Insulin Resistance and Adipose Tissue 893 Infectivity by SARS-CoV-2 Human 896 adipose tissue as a reservoir for memory CD4+ T cells and HIV Characterization of human 898 influenza A (H5N1) virus infection in mice: neuro-, pneumo-and adipotropic infection Human cytomegalovirus infection of human adipose-derived 902 stromal/stem cells restricts differentiation along the adipogenic lineage Adipose Tissue Is a Neglected 908 Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection MCP-1 contributes to macrophage infiltration into adipose 912 tissue, insulin resistance, and hepatic steatosis in obesity The Inflammatory Syndrome: The Role of Adipose Tissue Cytokines in 914 Metabolic Disorders Linked to Obesity Adipose Expression of Tumor Necrosis 916 Direct Role in Obesity-Linked Insulin Resistance TLR4 links innate 918 immunity and fatty acid-induced insulin resistance A Potential Role of Interleukin 10 in 999 COVID-19 Pathogenesis Upper airway gene expression reveals suppressed immune responses to 1004 SARS-CoV-2 compared with other respiratory viruses Proteomics of SARS-CoV-2-infected host cells reveals therapy targets A two-pronged 1009 strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein Inflammation 1012 and impaired adipogenesis in hypertrophic obesity in man Identification of functionally distinct fibro-1016 inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice Visceral and subcutaneous fat have different origins and evidence supports a mesothelial 1021 source Multi-omic profiling reveals widespread 1032 dysregulation of innate immunity and hematopoiesis in COVID-19 Characterizing the molecular regulation of 1036 inhibitory immune checkpoints with multimodal single-cell screens IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19 Plasma IP-10 and MCP-3 levels are highly associated with disease 1044 severity and predict the progression of COVID-19 Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic and sex Natural Killer cell 1052 activation, reduced ACE2, TMPRSS2, cytokines pseudovirus infectivity by MEK inhibitor treatment of human cells CXCL10 could drive longer duration of 1059 mechanical ventilation during COVID-19 ARDS The 1064 dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer 1065 outcome Clinical features of patients infected 1069 with 2019 novel coronavirus in Characterization of the cytokine storm reflects 1073 hyperinflammatory endothelial dysfunction in COVID-19 Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 1079 and Associations with Age and Disease Severity Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel 1083 Biomarker of Lethal SARS-CoV-2 Infection Activation of NF-κB and induction of proinflammatory cytokine 1085 expressions mediated by ORF7a protein of SARS-CoV-2 Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak LIF and the lung's stem cell niche: is failure to use LIF to protect against 1090 COVID-19 a grave omission in managing the pandemic? Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in 1102 Critically Ill COVID-19 Patients Role of interleukin 6 as a predictive factor for a severe course of Covid-19: 1105 retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak IL-6 Improves Energy and Glucose 1109 Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling Is IL-6 a key cytokine target for therapy in COVID-19? FABP4 Attenuates PPAR 1116 and Adipogenesis and Is Inversely Correlated With PPAR in Adipose Tissues Two distinct immunopathological 1121 profiles in autopsy lungs of COVID-19 Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with 1125 severe capillary congestion and variegated findings in lungs and other organs suggesting vascular 1126 dysfunction Characterisation of cardiac pathology in 23 1129 autopsies of lethal COVID-19 Adipose tissue macrophages: phenotypic 1131 plasticity and diversity in lean and obese states Perivascular macrophages in health and disease Macrophages and their relevance in 1135 Human Immunodeficiency Virus Type I infection The potential of lactoferrin, ovotransferrin and lysozyme as 1137 antiviral and immune-modulating agents in COVID-19 Structural and Functional Modeling of Human Lysozyme Reveals a 1140 62 Unique Nonapeptide, HL9, with Anti-HIV Activity † Antiviral effects of nisin lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus Influenza 1145 Virus Inhibits Lysozyme Secretion by Sputum Neutrophils in Subjects with Chronic Bronchial 1146 Systems biological assessment of 1152 immunity to mild versus severe COVID-19 infection in humans A single-cell atlas of the peripheral immune response in patients with severe 1157 COVID-19 Middle East respiratory syndrome coronavirus shows poor replication but significant induction 1160 of antiviral responses in human monocyte-derived macrophages and dendritic cells Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant 1165 Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for 1166 Cytokine Responses in Severe Acute Respiratory 1169 Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis Tropism, replication competence, and innate immune responses of the coronavirus SARS-1174 CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures Spike Protein of SARS-CoV-2 Activates Macrophages and Contributes to 1178 Induction of Acute Lung Inflammations in Mice Circuits between infected macrophages and T 1203 cells in SARS-CoV-2 pneumonia The Architecture of SARS-1205 SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples, Open Forum SARS-CoV-2 Total and Subgenomic RNA Viral Load in Hospitalized Patients Hijacking the translation apparatus by RNA viruses Cytokines Promote Wnt Signaling and Inflammation and Impair the 1216 Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes* Visceral fat shows the strongest association with the need of intensive care in patients with 1221 COVID-19 Visceral adipose 1223 tissue in patients with COVID-19: risk stratification for severity Computed Tomography Highlights 1227 Increased Visceral Adiposity Associated With Critical Illness in COVID-19 Adapting to obesity with adipose tissue inflammation Antiviral activity of aspirin against RNA 1232 66 viruses of the respiratory tract-an in vitro study Salicylate (Salsalate) in Patients With Type 2 Diabetes: 1235 A Randomized Trial Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Aspirin attenuates cytomegalovirus infectivity and gene 1240 expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells Use of proteomic 1244 analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid Cytosolic Phospholipase A2α Impairs an Early Step of Coronavirus Replication in Cell Culture vitro activity of acetylsalicylic acid on replication of varicella-1250 zoster virus Classical and alternative receptors 1252 for SARS-CoV-2 therapeutic strategy Systematic analysis of SARS-CoV-2 infection 1258 of an ACE2-negative human airway cell Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic 1261 features and central nervous system involvement of COVID-19 Isolation and Culture of Adipose-Derived Stromal Cells 1267 from Subcutaneous Fat Virological assessment of 1271 hospitalized patients with COVID-2019 The evolution of pulmonary pathology in fatal COVID-19 1274 disease: an autopsy study with clinical correlation STRING v11: protein-1277 protein association networks with increased coverage, supporting functional discovery in 1278 genome-wide experimental datasets Fast 1280 gene set enrichment analysis Association of high level gene expression of ACE2 in adipose tissue with 1282 mortality of COVID-19 infection in obese patients An 1284 Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in 1285 COVID-19 Infection and Severity Identification of Required Host Factors 1289 for SARS-CoV-2 Infection in Human Cells Acknowledgements: We thank the patients and their families for their consent to use their 1292 tissues. We would like to thank the Stanford Bariatric Surgery and Cardiothoracic Surgery clinic 1293 staff for assisting with participant recruitment and tissue harvesting University Hospital Tübingen, Germany) for providing samples and logistic support We would like to thank Anna Stalder and Jan Schneeberger (Institute of Medical Genetics and 1297 University Hospital of Basel, Switzerland) for data analysis and technical assistance The following reagent was deposited by the Centers for Disease Control and 1300 Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2 We thank Yael Rosenberg-Hasson, technical director of 1302 immunological assays at Stanford University's HIMC, for Luminex assays s BSL3 service center, for BSL3 surveillance and training. We are 1304 grateful to Angela Detweiler and the Chan Zuckerberg Biohub foundation for sequencing. 1305 1306 Funding: 1307 National Institutes of Health grant R21AI159024 American Diabetes Association Stanford University Innovative Medicines Accelerator COVID-19 Response grant (CAB, TLM) Botnar Research Centre for Child Health grant Emergency Response to COVID-19 grant Swiss National Science Foundation grant 320030_189275 (MSM) Bill and Melinda Gates Foundation OPP1113682 (JRA) 1317 1318 Author contributions: 1319 Conceptualization: GMC, HeC, CAB, TLM 1320 Methodology GPN 1326 Supervision: JRA, GPN, CAB, TLM 1327 Writing -original draft: GMC, KR Table 1 . 80-plex Luminex analysis of stromal vascular cells from human adipose tissue exposed 1416 to SARS-CoV-2. Table summarizing results Table 2 . Evidence of SARS-CoV-2 detection in adipose tissue from deceased individuals. Table 1425 summarizing SARS-CoV-2 PCR signals from 8 autopsy cases, seven of them from patients